The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
The Contribution of cocoa additive to cigarette smoking addiction
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Page 158 <strong>of</strong> 207 RIVM report 650270002<br />
Phenylethylamine<br />
diagnostic implications. <strong>The</strong> Journal <strong>of</strong> neuropsychiatry and clinical<br />
neurosciences , 1995; 7 (1):6-14.<br />
(17) Barroso N, Rodriguez M. Action <strong>of</strong> .beta.-phenylethylamine and related amines<br />
on nigrostriatal dopamine neurotransmission. Eur J Pharmacol, 1996; 297<br />
(3):195-203.<br />
(18) Ka<strong>to</strong> M, Ishida K, Chuma T, Abe K, Shigenaga T, Taguchi K et al. beta-<br />
Phenylethylamine modulates acetylcholine release in the rat striatum:<br />
involvement <strong>of</strong> a dopamine D-2 recep<strong>to</strong>r mechanism. European Journal <strong>of</strong><br />
Pharmacology, 2001; 418(1-2):65-71.<br />
(19) McCulloch J, Harper AM. Fac<strong>to</strong>rs influencing the response <strong>of</strong> the cerebral<br />
circulation <strong>to</strong> phenylethylamine. Neurology, 1979; 29 (2):201-207.<br />
(20) Dourish CT, Cooper SJ. Environmental experience produces qualitative changes<br />
in the stimulant effects <strong>of</strong> beta-phenylethylamine in rats. Psychopharmacology,<br />
1984; 84 (1):132-135.<br />
(21) Minchin RF, Barber HE, Ilett KF. Effect <strong>of</strong> prolonged desmethylimipramine<br />
administration on the pulmonary clearance <strong>of</strong> 5-hydroxytryptamine and betaphenylethylamine<br />
in rats. Drug metabolism and disposition the biological fate<br />
<strong>of</strong> chemicals, 1982; 10 (4):356-360.<br />
(22) Gillis CN, Roth JA. <strong>The</strong> fate <strong>of</strong> biogenic monoamines in perfused rabbit lung.<br />
British journal <strong>of</strong> pharmacology, 1977; 59 (4):585-590.<br />
(23) Youdim MB, Bakhle YS, Ben Harari RR. Inactivation <strong>of</strong> monoamines by the<br />
lung. Ciba Foundation symposium, 1980; 78:105-128.<br />
(24) Wu PH, Boul<strong>to</strong>n AA. Metabolism distribution, and disappearance <strong>of</strong> injected<br />
beta-phenylethylamine in the rat. Canadian journal <strong>of</strong> biochemistry, 1975; 53<br />
(1):42-50.<br />
(25) Tsuji M, Ohi K, Taga C, Myojin T, Takahashi S. Determination <strong>of</strong> .beta.phenylethylamine<br />
concentrations in human plasma, platelets, and urine and in<br />
animal tissues by high-performance liquid chroma<strong>to</strong>graphy with fluorometric<br />
detection. Anal Biochem, 1986; 153 (1),116-120.<br />
(26) McCulloch J, Harper AM. Phenylethylamine and cerebral blood flow. Possible<br />
involvement <strong>of</strong> phenylethylamine in migraine. Neurology, 1977; 27 (9):817-<br />
821.<br />
(27) Hoag GN, Hill A, Zaleski W. Urinary mandelic acid: identified in normal<br />
individuals following a single oral load <strong>of</strong> phenylethylamine. Clinical<br />
biochemistry, 1977; 10 (5):181-182.<br />
(28) Spatz H, Spatz N. Sero<strong>to</strong>nina plaquetaria en enfermos depresivos endogenos y<br />
controles normales. [Platelet sero<strong>to</strong>nin in endogenous depressive patients and<br />
normal controls]. Acta psiquiatrica y psicologica de America latina, 1995; 41<br />
(3):230-236.
Change language